Dinglan Zuo
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 7
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 3
-
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 2
- Co-authors
- Yunfei Yuan (23 shared papers)Wei He (18 shared papers)Jiliang Qiu (21 shared papers)Binkui Li (16 shared papers)Chenwei Wang (14 shared papers)Wenwu Liu (11 shared papers)Yuanping Zhang (10 shared papers)Zhiwen Yang (10 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (2 papers)Journal of Cancer (2 papers)Nature Communications (2 papers)Cell Death Discovery (1 paper)Therapeutic Advances in Medical Oncology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Dinglan Zuo
24 papers receiving 570 citations
Peers
Comparison fields: 5 of 50
- Hepatology 176
- Cancer Research 143
- Molecular Biology 221
- Oncology 70
- Immunology 46
Countries citing papers authored by Dinglan Zuo
This map shows the geographic impact of Dinglan Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinglan Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinglan Zuo more than expected).
Fields of papers citing papers by Dinglan Zuo
This network shows the impact of papers produced by Dinglan Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinglan Zuo. The network helps show where Dinglan Zuo may publish in the future.
Co-authors
The 25 scholars most cited alongside Dinglan Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 75 | |
| 2 | 2020 | 69 | |
| 3 | 2022 | 56 | |
| 4 | 2023 | 54 | |
| 5 | 2019 | 52 | |
| 6 | 2017 | 37 | |
| 7 | 2021 | 29 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 27 | |
| 10 | 2024 | 24 | |
| 11 | 2020 | 21 | |
| 12 | 2023 | 17 | |
| 13 | 2023 | 15 | |
| 14 | 2022 | 15 | |
| 15 | 2021 | 13 | |
| 16 | 2024 | 12 | |
| 17 | 2019 | 7 | |
| 18 | 2024 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 4 |
About Dinglan Zuo
Dinglan Zuo is a scholar working on Molecular Biology, Cancer Research, Hepatology, Pulmonary and Respiratory Medicine and Oncology, having authored 25 papers that have together received 574 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Hepatology (176 citations), Cancer Research (143 citations), Molecular Biology (221 citations), Oncology (70 citations) and Immunology (46 citations). Dinglan Zuo has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yunfei Yuan, Wei He, Jiliang Qiu, Binkui Li, Chenwei Wang, Wenwu Liu, Yuanping Zhang, Zhiwen Yang, Yadi Liao and Yichuan Yuan. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Journal of Cancer, Nature Communications, Cell Death Discovery and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.